Genomic cartography of varicella-zoster virus: A complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences

Virology

Volumn 359, Issue 2, 2007, Pages 447-458

  Tyler, S D ^a   Peters, G A ^a   Grose, C ^b   Severini, A ^a,c   Gray, M J ^a   Upton, C ^d   Tipples, G A ^a,c  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Genomics; Genotype; Phylogeny; Recombination; Varicella zoster virus; VZV

Indexed keywords

CHICKENPOX VACCINE;

AMINO ACID SUBSTITUTION; ARTICLE; DNA REPLICATION ORIGIN; GENETIC STABILITY; GENETIC VARIABILITY; GENOMICS; HERPES VIRUS; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN DIFFERENCE; VARICELLA ZOSTER VIRUS; VIRUS GENOME; VIRUS MUTANT; VIRUS RECOMBINATION;

BASE SEQUENCE; GENOME, VIRAL; HERPESVIRUS 3, HUMAN; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PHENOTYPE; VACCINES, ATTENUATED; VARIATION (GENETICS); VIRAL PROTEINS; VIRAL VACCINES;

HUMAN HERPESVIRUS 3;

EID: 33847015723     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.09.037     Document Type: Article

References (53)

1. Argaw T., Cohen J.I., Klutch M., Lekstrom K., Yoshikawa T., Asano Y., and Krause P.R. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates. J. Infect. Dis. 181 (2000) 1153-1157
2. Barrett-Muir W., Hawrami K., Clarke J., and Breuer J. Investigation of varicella-zoster virus variation by heteroduplex mobility assay. Arch. Virol. Suppl. 17 (2001) 17-25
3. Barrett-Muir W., Scott F.T., Aaby P., John J., Matondo P., Chaudhry Q.L., Siqueira M., Poulsen A., Yaminishi K., and Breuer J. Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J. Med. Virol. 70 (2003) S42-S47
4. Biron K.K., Fyfe J.A., Noblin J.E., and Elion G.B. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus. Am. J. Med. 73 (1982) 383-386
5. Carr M.J., McCormack G.P., and Crowley B. Genetic variation in clinical varicella-zoster virus isolates collected in Ireland between 2002 and 2003. J. Med. Virol. 73 (2004) 131-136
6. Chen D., and Olivo P.D. Expression of the varicella-zoster virus origin-binding protein and analysis of its site-specific DNA-binding properties. J. Virol. 68 (1994) 3841-3849
7. Cohrs R.J., Gilden D.H., Gomi Y., Yamanishi K., and Cohen J.I. Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of varicella-Zoster virus. J. Virol. 80 (2006) 2076-2082
8. Davison A.J. Structure of the genome termini of varicella-zoster virus. J. Gen. Virol. 65 (1984) 1969-1977
9. Davison A.J., and Scott J.E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67 (1986) 1759-1816
10. Davison A.J., and Wilkie N.M. Nucleotide sequences of the joint between the L and S segments of herpes simplex virus types 1 and 2. J. Gen. Virol. 55 (1981) 315-331
11. Deng H., and Dewhurst S. Functional identification and analysis of cis-acting sequences which mediate genome cleavage and packaging in human herpesvirus 6. J. Virol. 72 (1998) 320-329
12. Esteban D.J., Da Silva M., and Upton C. New bioinformatics tools for viral genome analyses at Viral Bioinformatics-Canada. Pharmacogenomics 6 (2005) 271-280
13. Faga B., Maury W., Bruckner D.A., and Grose C. Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology 280 (2001) 1-6
14. Gomi Y., Imagawa T., Takahashi M., and Yamanishi K. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity. J. Med. Virol. 61 (2000) 497-503
15. Gomi Y., Sunamachi H., Mori Y., Nagaike K., Takahashi M., and Yamanishi K. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J. Virol. 76 (2002) 11447-11459
16. Grose C. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005. J. Clin. Virol. 33 (2005) 89-98
17. Grose C., Tyler S., Peters G., Hiebert J., Stephens G.M., Ruyechan W.T., Jackson W., Storlie J., and Tipples G.A. Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype. J. Virol. 78 (2004) 6799-6807
18. Hawrami K., Hart I.J., Pereira F., Argent S., Bannister B., Bovill B., Carrington D., Ogilvie M., Rawstorne S., Tryhorn Y., and Breuer J. Molecular epidemiology of varicella-zoster virus in East London, England, between 1971 and 1995. J. Clin. Microbiol. 35 (1997) 2807-2809
19. Ida M., Kageyama S., Sato H., Kamiyama T., Toyomoto T., Ozaki T., Kajita Y., Morohashi M., and Shiraki K. Characterization of acyclovir susceptibility and genetic stability of varicella-zoster viruses isolated during acyclovir therapy. J. Dermatol. Sci. 23 (2000) 63-72
20. Kamiyama T., Kurokawa M., and Shiraki K. Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir. J. Gen. Virol. 82 (2001) 2761-2765
21. Kingchington P.R., and Cohen J.I. Viral Proteins. In: Arvin A.M., and Gershon A.A. (Eds). varicella-Zoster Virus (2000), Cambridge Univ. Press, Cambridge, UK 70-104
22. Kinchington, P.R., Remenick, J., Ostrove, J.M., Straus, S.E., Ruyechan, W.T., Hay, J., 1986. Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C. 59, 660-8.
23. Kumar S., Tamura K., and Nei M. MEGA3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief. Bioinform. 5 (2004) 150-163
24. LaRussa P., Lungu O., Hardy I., Gershon A., Steinberg S.P., and Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J. Virol. 66 (1992) 1016-1020
25. LaRussa P., Steinberg S., Arvin A., Dwyer D., Burgess M., Menegus M., Rekrut K., Yamanishi K., and Gershon A. Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. J. Infect. Dis. 178 (1998) S64-S66
26. Loparev V.N., Argaw T., Krause P.R., Takayama M., and Schmid D.S. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J. Clin. Microbiol. 38 (2000) 3156-3160
27. Loparev V.N., Gonzalez A., Deleon-Carnes M., Tipples G., Fickenscher H., Torfason E.G., and Schmid D.S. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J. Virol. 78 (2004) 8349-8358
28. McVoy M.A., Nixon D.E., Adler S.P., and Mocarski E.S. Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome. J. Virol. 72 (1998) 48-56
29. Moffat J.F., Zerboni L., Kinchington P.R., Grose C., Kaneshima H., and Arvin A.M. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72 (1998) 965-974
30. Morfin F., Thouvenot D., De Turenne-Tessier M., Lina B., Aymard M., and Ooka T. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir. Antimicrob. Agents Chemother. 43 (1999) 2412-2416
31. Muir W.B., Nichols R., and Breuer J. Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J. Virol. 76 (2002) 1971-1979
32. Natoli S., Ciotti M., Paba P., Testore G.P., Palmieri G., Orlandi A., Sabato A.F., and Leonardis F. A novel mutation of varicella-zoster virus associated to fatal hepatitis. J. Clin. Virol. 37 (2006) 72-74
33. Nugent J., Birch-Machin I., Smith K.C., Mumford J.A., Swann Z., Newton J.R., Bowden R.J., Allen G.P., and Davis-Poynter N. Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. J. Virol. 80 (2006) 4047-4060
34. Peters G.A., Tyler S.D., Grose C., Severini A., Gray M.J., Upton C., and Tipples G.A. A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J. Virol. 80 (2006) 9850-9860
35. Quinlivan M., Hawrami K., Barrett-Muir W., Aaby P., Arvin A., Chow V.T., John T.J., Matondo P., Peiris M., Poulsen A., Siqueira M., Takahashi M., Talukder Y., Yamanishi K., Leedham-Green M., Scott F.T., Thomas S.L., and Breuer J. The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J. Infect. Dis. 186 (2002) 888-894
36. Roberts G.B., Fyfe J.A., Gaillard R.K., and Short S.A. Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment. J. Virol. 65 (1991) 6407-6413
37. Santos R.A., Padilla J.A., Hatfield C., and Grose C. Antigenic variation of varicella zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain. Virology 249 (1998) 21-31
38. Santos R.A., Hatfield C.C., Cole N.L., Padilla J.A., Moffat J.F., Arvin A.M., Ruyechan W.T., Hay J., and Grose C. Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology 275 (2000) 306-317
39. Stow N.D., and Davison A.J. Identification of a varicella-zoster virus origin of DNA replication and its activation by herpes simplex virus type 1 gene products. J. Gen. Virol. 67 (1986) 1613-1623
40. Stow N.D., Weir H.M., and Stow E.C. Analysis of the binding sites for the varicella-zoster virus gene 51 product within the viral origin of DNA replication. Virology 177 (1990) 570-577
41. Takada M., Suzutani T., Yoshida I., Matoba M., and Azuma M. Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region. J. Clin. Microbiol. 33 (1995) 658-660
42. Takahashi M. Development and characterization of a live varicella vaccine (Oka strain). Biken J. 27 (1984) 31-36
43. Takayama M., and Takayama N. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis. J. Clin. Virol. 29 (2004) 113-119
44. Thomson B.J., Dewhurst S., and Gray D. Structure and heterogeneity of the a sequences of human herpesvirus 6 strain. J. Virol. 68 (1994) 3007-3014
45. Tipples G.A., Stephens G.M., Sherlock C., Bowler M., Hoy B., Cook D., and Grose C. New variant of varicella-zoster virus. Emerg. Infect. Dis. 8 (2002) 1504-1505
46. Tyler S.D., Peters G.A., and Severini A. Complete genome sequence of cercopithecine herpesvirus 2 (SA8) and comparison with other simplexviruses. Virology 331 (2005) 429-440
47. Vassilev V. Stable and consistent genetic profile of Oka varicella vaccine virus is not linked with appearance of infrequent breakthrough cases postvaccination. J. Clin. Microbiol. 43 (2005) 5415-5417
48. Wagenaar T.R., Chow V.T., Buranathai C., Thawatsupha P., and Grose C. The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades. Vaccine 21 (2003) 1072-1081
49. Wirgart B.Z., Estrada V., Jackson W., Linde A., and Grose C. A novel varicella-zoster virus gE mutation discovered in two Swedish isolates. J. Clin. Virol. 37 (2006) 134-136
50. Yoshida M., and Tamura T. An analytical method for R5 repeated structure in varicella-zoster virus DNA by polymerase chain reaction. J. Virol. Methods 80 (1999) 213-215
51. Yoshida M., Tamura T., and Hiruma M. Analysis of strain variation of R1 repeated structure in varicella-zoster virus DNA by polymerase chain reaction. J. Med. Virol. 58 (1999) 76-78
52. Yoshida M., Tamura T., Miyasaka K., Shimizu A., Ohashi N., and Itoh M. Analysis of numbers of repeated units in R2 region among varicella-zoster virus strains. J. Dermatol. Sci. 31 (2003) 129-133
53. Zerboni L., Hinchliffe S., Sommer M.H., Ito H., Besser J., Stamatis S., Cheng J., Distefano D., Kraiouchkine N., Shaw A., and Arvin A.M. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. Virology 332 (2005) 337-346